These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12898182)

  • 1. Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice.
    Abou El Hassan MA; Kedde MA; Zwiers UT; Tourn E; Haenen GR; Bast A; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):371-6. PubMed ID: 12898182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice.
    Abou El Hassan MA; Kedde MA; Zwiers UT; Bast A; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):306-10. PubMed ID: 12721758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of monohydroxyethylrutoside in healthy volunteers.
    Willems AM; Bruynzeel AM; Kedde MA; van Groeningen CJ; Bast A; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2006 May; 57(5):678-84. PubMed ID: 16136309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
    Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice.
    Bruynzeel AM; Vormer-Bonne S; Bast A; Niessen HW; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):509-14. PubMed ID: 17177067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.
    van Acker FA; van Acker SA; Kramer K; Haenen GR; Bast A; van der Vijgh WJ
    Clin Cancer Res; 2000 Apr; 6(4):1337-41. PubMed ID: 10778960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice.
    Chaves JS; Leal PC; Pianowisky L; Calixto JB
    Planta Med; 2008 Nov; 74(14):1678-83. PubMed ID: 18951339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
    Goudah A; Abo El Sooud K; Abd El-Aty AM
    Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice.
    Lukka PB; Paxton JW; Kestell P; Baguley BC
    Cancer Chemother Pharmacol; 2010 May; 65(6):1145-52. PubMed ID: 19774378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
    Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R
    Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the metabolites of the antioxidant flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside in mice.
    Jacobs H; Peters R; den Hartog GJ; van der Vijgh WJ; Bast A; Haenen GR
    Drug Metab Dispos; 2011 May; 39(5):750-6. PubMed ID: 21266594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatography with electrochemical detection for the determination of 7-monohydroxyethylrutoside in plasma.
    El Hassan MA; Kedde MA; Bast A; van der Vijgh WJ
    J Chromatogr B Biomed Sci Appl; 2001 Mar; 752(1):115-21. PubMed ID: 11254185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity.
    van Acker FA; Boven E; Kramer K; Haenen GR; Bast A; van der Vijgh WJ
    Clin Cancer Res; 2001 May; 7(5):1378-84. PubMed ID: 11350909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained protective effects of 7-monohydroxyethylrutoside in an in vivo model of cardiac ischemia-reperfusion.
    De Celle T; Heeringa P; Strzelecka AE; Bast A; Smits JF; Janssen BJ
    Eur J Pharmacol; 2004 Jun; 494(2-3):205-12. PubMed ID: 15212976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
    Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
    Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
    Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.